Blood-stable, cholesterol-free liposomes
AssigneeThe University of Tennessee Research Corporation
InventorsLeaf Huang, Dexi Liu
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe University of Tennessee Research Corporation
InventorsLeaf Huang, Dexi Liu
Estimating the term…
Small unilamellar liposomes (d<600 nm) comprising an unsaturated phosphatidylethanolamine (PE) such as dioleoyl PE (DOPE) and a fatty acid such as oleic acid (OA) are stabilized by adding to a freshly prepared liposome suspension, an amphipile which has a high tendency to form micelles. Examples are shown for the following micelle-forming amphiphiles: lysophospholipide, gangliosides (GM.sub.1 and GTlb), sulfatide, synthetic glycopholipids such as sialo-lactosyl phosphatidylethanolamine, liopohilic drugs such as cytosine arabinoside diphosphate diacyglycerol, and proteins such as cytochrome b.sub.5, human high density lipoprotein (HDL), and human glycophorin A. The stabilized liposomes are resistant to the lytic action of albumin, the major blood component which causes the lysis of this type of liposome. Prior to the present invention, liposomes comprising PE and OA were typically stabilized by the incorporation of cholesterol.
A method of stabilizing freshly prepared, small, unilamellar liposomes in blood or body fluids, said liposomes consisting essentially of an unsaturated phosphatidylethanolamine and a fatty acid as the major components of the liposome preparation, which comprises adding a blood or body fluid stabilizing amount of a micelle-forming amphiphile to a suspension of said liposomes.
A method of stabilizing freshly prepared, small, unilamellar liposomes in blood or other body fluids, said liposomes consisting essentially of an unsaturated phosphatidylethanolamine and a fatty acid as the major components of the liposome preparation, which comprises mixing said liposomes with a stabilizing amount of human plasma, serum or whole blood.
A method of delivering one or more drugs to a mammalian patient so as to greatly reduce the chance of cross-contamination and cross-reaction of the blood of said patient with blood products from other sources, said method comprising the steps of:
Dependencies are inferred from the claim text.